Clinical Trial Update: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT) [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial comparing Cerebrolysin to Donepezil in patients with mild to moderate Alzheimer's disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Cerebrolysin
• Donepezil (donepezil)

Snippet

Sponsor: Ever Neuro Pharma GmbH | Conditions: Alzheimer Disease | Phase 4 | Status: WITHDRAWN